Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA clinical research conference

This article was originally published in The Gray Sheet

Executive Summary

FDA clinical research conference: "Current Issues in Human Subject Protection: An FDA Perspective" is scheduled for Sept. 13 at the Natcher Auditorium on the National Institutes of Health campus in Bethesda, Maryland. FDA personnel will discuss "current regulatory issues," including "the practical applications of the protective mechanisms required by FDA regulations such as the institutional review board (IRB) system and the process of obtaining informed consent," according to an FDA announcement. For information, contact the agency's Office of Health Affairs at 301/827-1685...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel